Published: 24 May 2019
Version: 1.0Print this document
Unmodified use of the appropriate UK Template Model Agreement helps to speed up the contracting process for studies carried out in the NHS, by removing site-by-site review and negotiation. Unmodified use is a general expectation and, in some cases, an obligation for the NHS - as set out in the National Directive on Commercial Contract Research Studies. This standardised approach protects all parties, enables studies to start earlier and gives NHS patients faster access to innovative treatments in high quality research.
The suite of model site agreements are supported by guidance which sets out the aims and provides details on how the agreement should be used in the development of contracts for clinical research sponsored by pharmaceutical, biopharmaceutical or medical technology companies.
Access the suite of model agreements
For more information and to access the latest versions of model agreement templates, visit the IRAS website.
model Industry Collaborative Research Agreement (mICRA)
The model Industry Collaborative Research Agreement (mICRA) launched in February 2011 aims to support clinical research collaborations involving the pharmaceutical and biotechnology industries, academia and NHS organisations across the UK.
A Decision Tree is available to guide users in identifying when studies are collaborative and whether mICRA is applicable.
Feedback on the use of the mICRA is welcomed to help inform its future development. Email comments to firstname.lastname@example.org.